This group of researchers brings together clinical specialists from the Neurology Department of the Hospital Clínico San Carlos and other related services within the Hospital’s Neurosciences Institute, as well as related research laboratories, mainly in neurodegenerative and demyelinating diseases with cellular and animal models. The group has a special area in repair neurology, with research on undifferentiated cells as well as neurogenetics.
The common denominator of these researchers is the work in projects and research programmes in neurological and neuromuscular diseases, from methodology, epidemiology, mechanisms, clinical, and therapeutics, in coordination with other groups of the Institute, as well as basic research. Focus on neuromodulation research and clinical trials.
Its research project blocks can be classified as follows:
Research into the role of the brain as a reservoir for SARS-Cov2 and the role of the virus as a trigger for neurodegenerative diseases has recently been incorporated.
It is one of the groups with the greatest presence in publications and scientific activity in clinical neurology, it carries out training programmes both within and outside the hospital. The group uses resources shared with other groups at the Institute of Neurosciences of the HCSC, in terms of translational research, has resources for storing clinical material and structuring databases in accordance with current legislation. It includes two basic research laboratories. It also has an organisation for clinical trials. The group has a broad vocation in the publication of impact articles, with an annual average of more than 20 articles per year, mostly in Q1 and Q2 journals. Its members sit on editorial boards of high impact journals.
To advance knowledge of neurological diseases, with special attention to: